Stock Events

Stock Events

Intelligent Bio Solutions 

€4.92
82
-€0.00-0% Monday 20:00

Statistics

Day High
5.42
Day Low
2.5
52W High
49.2
52W Low
2.5
Volume
8,076
Avg. Volume
0
Mkt Cap
14.85M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2025
Q1 2026
Q2 2026
Next
-1.54
-0.63
0.28
1.19
Expected EPS
-1.1220150000000002
Actual EPS
N/A

Financials

-346.26%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
2.76MRevenue
-9.56MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap226.94B
Thermo Fisher Scientific offers a broad range of services and products for research, analysis, discovery, and diagnostics, directly competing with INBS's offerings in the biotech and healthcare solutions space.
Danaher
DHR
Mkt Cap145.98B
Danaher Corporation operates in the life sciences, diagnostics, and environmental industries, offering similar products and technologies that compete with INBS's portfolio.
Illumina
ILMN
Mkt Cap32.95B
Illumina, Inc. specializes in DNA sequencing and array-based technologies, competing with INBS in the genomic analysis and diagnostics sectors.
Bio-Rad Laboratories
BIO
Mkt Cap10.32B
Bio-Rad Laboratories, Inc. provides a variety of instruments and reagents for research and clinical diagnostic applications, directly competing with INBS in the life sciences and healthcare market.
Agilent Technologies
A
Mkt Cap42.53B
Agilent Technologies, Inc. offers instruments, services, consumables, applications, and expertise, competing with INBS in areas such as diagnostics and genomics.
Waters
WAT
Mkt Cap40.22B
Waters Corporation produces analytical standards and instruments, including for chromatography and mass spectrometry, competing with INBS in the analytical and diagnostics sectors.
Bruker
BRKR
Mkt Cap8.91B
Bruker Corporation designs and manufactures scientific instruments and analytical and diagnostic solutions, competing with INBS in providing comprehensive solutions for the biotech industry.
Guardant Health
GH
Mkt Cap21.66B
Qiagen NV
QGEN
Mkt Cap8.98B
QIAGEN N.V. offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing with INBS in the field of molecular diagnostics and research.

About

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.
Show more...
CEO
Harry Simeonidis
Employees
60
Country
United States
ISIN
US36151G7097
WKN
000A401UY

Listings

STU
DE
12Q0.STU
XNAS
US
INBS
MU
DE
12Q.MU
BOATS
BOATS
INBS.BOATS

0 Comments

Share your thoughts

FAQ

What is Intelligent Bio Solutions stock price today?▼
The current price of 12Q0.MU is €4.92 EUR — it has decreased by -0% in the past 24 hours. Watch Intelligent Bio Solutions stock price performance more closely on the chart.
What is Intelligent Bio Solutions stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Intelligent Bio Solutions stocks are traded under the ticker 12Q0.MU.
Is Intelligent Bio Solutions stock price growing?▼
12Q0.MU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Intelligent Bio Solutions has showed a +900% increase.
What is Intelligent Bio Solutions market cap?▼
Today Intelligent Bio Solutions has the market capitalization of 14.85M
When is the next Intelligent Bio Solutions earnings date?▼
Intelligent Bio Solutions is going to release the next earnings report on November 05, 2026.
What were Intelligent Bio Solutions earnings last quarter?▼
12Q0.MU earnings for the last quarter are -1.35 EUR per share, whereas the estimation was -1.35 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Intelligent Bio Solutions revenue for the last year?▼
Intelligent Bio Solutions revenue for the last year amounts to 2.76M EUR.
What is Intelligent Bio Solutions net income for the last year?▼
12Q0.MU net income for the last year is -9.56M EUR.
How many employees does Intelligent Bio Solutions have?▼
As of September 09, 2026, the company has 60 employees.
In which sector is Intelligent Bio Solutions located?▼
Intelligent Bio Solutions operates in the Health & Wellness sector.
When did Intelligent Bio Solutions complete a stock split?▼
The last stock split for Intelligent Bio Solutions was on December 16, 2025 with a ratio of 1:10.
Where is Intelligent Bio Solutions headquartered?▼
Intelligent Bio Solutions is headquartered in NEW YORK, United States.